From October 1, 2021 to December 31, 2021, the company has repurchased 3,390,700 shares, representing 0.31% for CNY 93.27 million. With this, the company has completed the repurchase of 12,070,607 shares, representing 1.09% for CNY 327.78 million under the buyback announced on July 26, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.56 CNY | 0.00% | -5.29% | -9.49% |
Apr. 23 | Salubris Pharmaceuticals' Q1 Profit Falls 5% Despite 23% Rise in Operating Income | MT |
Apr. 23 | Salubris Pharmaceuticals to Raise Capital of US Unit by $35 Million | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.49% | 4.47B | |
+21.63% | 44.11B | |
+23.03% | 22.71B | |
+18.22% | 15.15B | |
+12.66% | 13.56B | |
+60.18% | 12.7B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.92% | 5.63B |
- Stock Market
- Equities
- 002294 Stock
- News Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Tranche Update on Shenzhen Salubris Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on July 26, 2021.